Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Biorem Inc BIRMF


Primary Symbol: V.BRM

Biorem Inc. is a Canada-based clean technology company. The Company designs, manufactures and distributes a line of air emissions control systems used to eliminate odors, volatile organic compounds (VOCs) and hazardous air pollutants (HAPs). It operates through one reportable segment, which involves the manufacture and sale of pollution control systems. Its solutions include BASYS and BiofiltAIR biofilter, MYTILUS biotrickling filter, multi-stage SYNERGY system, biogas desulfurization, dry scrubber adsorption systems and cannabis odor control. Its BASYS and BiofiltAIR biofilter systems are suited for odor control applications, especially when removing reduced sulfur compounds or VOCs. It offers biofiltration medias, which include BIOSORBENS, XLD, BIOPAK and BIOROLL & BIOBLOK. The Company's service solutions include system upgrades, preventative maintenance, and replacement and spare parts. Its other services dispersion modeling, permit applications and community outreach programs.


TSXV:BRM - Post by User

<< Previous
Bullboard Posts
Next >>
Post by Possibleidiot01on May 01, 2024 7:14am
61 Views
Post# 36016693

Preview Planet Microcap

Preview Planet Microcap
https://stocksandstones.substack.com/p/preview-planet-microcap-showcase
 
 

From April 30 to May 2, I’ll attend the Planet MicroCap Showcase conference in Las Vegas with my analyst at Rivemont.

I’ve been attending this conference for several years and really enjoy the two-and-a-half-day format. On the first half-day, you hear keynote speeches, followed by company presentations and one-on-one meetings on the remaining two days.

Close to 100 presenting companies are involved in this year’s edition, including 21 Canadian companies.

On May 1, I will be moderating six fireside Q&A sessions with some of my favourite Canadian companies:

  • Biorem (TSX-V: BRM)

  • BioSyent (TSX-V: RX)

  • BQE Water (TSX-V: BQE)

  • OneSoft Solutions (TSX-V: OSS)

  • Sabio Holdings (TSX-V: SBIO)

  • Yerba Brands (TSX-V: YERB-U)

All the company presentations, including the fireside Q&A sessions, will be broadcast live through the online portal, so I encourage you to register and check it out.

On the last day, my analyst and I will sit down with 18 companies for 30-minute one-on-one meetings. Yes, it will be a gruelling day! (but hopefully very productive)

We typically meet companies for one of three reasons:

  1. The Rivemont MicroCap Fund owns the stock, and we want to catch up with management (5 out of 18 meetings).

  2. We are actively researching the company to potentially add it to the portfolio (5 out of 18 meetings)

  3. We want to connect with the company for the first time and get to know management a little more (8 out of 18 meetings).

I’ll highlight one opportunity in each category to give you a flavour of the meetings I’ll be taking.

1. Biorem (TSX-V: BRM)

Biorem is a leading clean technology company that designs, manufactures and distributes a comprehensive line of high-efficiency air emissions control systems used to eliminate odours, volatile organic compounds, and hazardous air pollutants.

The company recently published phenomenal results for its fourth quarter of 2023, earning $0.15 per share in one quarter alone (the stock currently trades below $2.00). Given the $50-million backlog, it looks like 2024 could be another breakout year for Biorem. I’ll be looking to learn more about the expected timeline to deliver this backlog and details on the sales pipeline to replenish this backlog over the coming years.



<< Previous
Bullboard Posts
Next >>